Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents.

Introduction: Cancer, a significant global health concern, necessitates innovative treatments. The pivotal role of chronic inflammation in cancer development underscores the urgency for novel therapeutic strategies. Benzothiazole derivatives exhibit promise due to their distinctive structures and broad spectrum of biological effects. This study aims to explore new anti-tumor small molecule drugs that simultaneously anti-inflammatory and anticancer based on the advantages of benzothiazole frameworks. Methods: The compounds were characterized by nuclear magnetic resonance (NMR), liquid chromatograph-mass spectrometer (LC-MS) and high performance liquid chromatography (HPLC) for structure as well as purity and other related physicochemical properties. The effects of the compounds on the proliferation of human epidermoid carcinoma cell line (A431) and human non-small cell lung cancer cell lines (A549, H1299) were evaluated by MTT method. The effect of compounds on the expression levels of inflammatory factors IL-6 and TNF-α in mouse monocyte macrophages (RAW264.7) was assessed using enzyme-linked immunosorbent assay (ELISA). The effect of compounds on apoptosis and cell cycle of A431 and A549 cells was evaluated by flow cytometry. The effect of compounds on A431 and A549 cell migration was evaluated by scratch wound healing assay. The effect of compounds on protein expression levels in A431 and A549 cells was assessed by Western Blot assay. The physicochemical parameters, pharmacokinetic properties, toxicity and drug similarity of the active compound were predicted using Swiss ADME and admetSAR web servers. Results: Twenty-five novel benzothiazole compounds were designed and synthesized, with their structures confirmed through spectrogram verification. The active compound 6-chloro-N-(4-nitrobenzyl) benzo[d] thiazol-2-amine (compound B7) was screened through a series of bioactivity assessments, which significantly inhibited the proliferation of A431, A549 and H1299 cancer cells, decreased the activity of IL-6 and TNF-α, and hindered cell migration. In addition, at concentrations of 1, 2, and 4 µM, B7 exhibited apoptosis-promoting and cell cycle-arresting effects similar to those of the lead compound 7-chloro-N-(2, 6-dichlorophenyl) benzo[d] thiazole-2-amine (compound 4i). Western blot analysis confirmed that B7 inhibited both AKT and ERK signaling pathways in A431 and A549 cells. The prediction results of ADMET indicated that B7 had good drug properties. Discussion: This study has innovatively developed a series of benzothiazole derivatives, with a focus on compound B7 due to its notable dual anticancer and anti-inflammatory activities. B7 stands out for its ability to significantly reduce cancer cell proliferation in A431, A549, and H1299 cell lines and lower the levels of inflammatory cytokines IL-6 and TNF-α. These results position B7B7 as a promising candidate for dual-action cancer therapy. The study's mechanistic exploration, highlighting B7's simultaneous inhibition of the AKT and ERK pathways, offers a novel strategy for addressing both the survival mechanisms of tumor cells and the inflammatory milieu facilitating cancer progression.

Molybdate-Templated Luminescent Silver Alkynyl Nanoclusters: Total Structure Determination and Optical Property Analysis.

Two novel MoO42--templated luminescent silver alkynyl nanoclusters with 20-nuclearity ([(MoO42-)@Ag20(C≡CtBu)8(Ph2PO2)7(tfa)2]·(tfa-) (1)) and 18-nuclearity ([(MoO42-)@Ag18(C≡CtBu)8(Ph2PO2)7]·(OH) (2)) (tfa = trifluoroacetate) were synthesized with the green light maximum emissions at 507 and 516 nm, respectively. The nanoclusters were investigated and characterized by single-crystal X-ray crystallography, electrospray ionization mass spectrum (ESI-MS), X-ray photoelectron spectroscopy, thermogravimetry (TG), photoluminescence (PL), ultraviolet-visible (UV-vis) spectroscopy, and density functional theory calculations (DFT). The two nanoclusters differ in their structure by a supplementary [Ag2(tfa)2] organometallic surface motif, which significantly participates in the frontier molecular orbitals of 1, resulting in similar bonding patterns but different optical properties between the two clusters. Indeed, both nanoclusters show strong temperature-dependent photoluminescence properties, which make them potential candidates in the fields of optical devices for further applications.

Prognostic value of angiogenic T cells in hepatitis B-induced liver cirrhosis.

This study was performed to investigate the frequency of angiogenic T cells (CD4+ Tang cells) among CD4+ T cells in patients with hepatitis B-induced liver cirrhosis (HBV-LC) and to evaluate the predictive role of these cells in the clinical outcome. In total, 185 patients with HBV-LC were recruited to measure the frequency of CD4+ Tang cells and chemokine levels using flow cytometry. RESULTS: There was 11.4% of death after 3-momth follow-up. The AUC for the ability of the frequency of CD4+ Tang cell to predict death was 0.724 (higher than those for the MELD score, FIB-4 score, and Child-Pugh classification). Cox regression analysis revealed an association between the frequency of CD4+ Tang cells and a 3-month survival chance. CONCLUSIONS: The lower frequency of CD4+ T ang cells was correlated with the severity of HBV-LC and may serve as a prognostic predictor.

Experimental demonstration of a real-time multi-user uplink UWOC system based on SIC-free NOMA.

Non-orthogonal multiple access (NOMA) has been studied as a promising multiple access technology for optical communication systems due to its superior spectral efficiency. However, the multi-user communication systems that employ NOMA with successive interference cancellation (SIC) suffer from error propagation (EP). Besides, the issue of non-ideal rise and fall time of the received signal can result in severe bit error rate (BER) degradation while decoding by the SIC technique. In this paper, we propose a straightforward two-stage program judgment filter (PJF) for signal reshaping and a SIC-free decoding method for NOMA. Based on the amplitude threshold (AT) decoding method, we demonstrate a real-time, two-user uplink underwater wireless optical communication (UWOC) system via field programmable gate arrays (FPGAs). With a power allocation ratio (PAR) of 2:1 (user 1: user 2), the established real-time NOMA-based UWOC system utilizing commercial light emitting diodes (LEDs) achieves a data rate of 30 Mbps for each user with BERs of 7.8 × 10-6 and 3 × 10-4 for user 1 and user 2, respectively. The results show that the AT-based NOMA can obtain a lower BER compared to the SIC-based NOMA, especially for user 2.

Contralateral C7 nerve transfer via the prespinal route in treatment of spastic paralysis of upper limb after cerebral palsy.

BACKGROUND: Upper limb spasticity leads to different degrees of disabilities in cerebral palsy, which seriously affects the life of patients. Contralateral C7 nerve transfer has been shown to improve function and reduce spasticity in the affected upper limb with post-stroke hemiplegia. However, reports about the efficacy of this procedure in treating upper limb spasticity caused by hemiplegic cerebral palsy were limited. CASE DESCRIPTION: We reported two cases (a 23-year-old male and a 18-year-old female) who suffered from hemiplegic cerebral palsy with unilateral sustained upper limb spasticity and underwent contralateral C7 nerve transfer in adulthood. The scores of Fugel-Meyer and ROM of the affected upper limbs were observed before and after surgery. Compared with the preoperative, scores of the latest follow-up both were significantly improved. The muscle tension of the upper limbs decreased, and the symptoms of spasm were alleviated. CONCLUSIONS: Considering contralateral C7 nerve transfer could effectively relieve spasticity and improve upper limb activity, it can be recommended as one of the reliable methods to manage spasticity and dystonia of upper limbs in patients with hemiplegic cerebral palsy.

Boosting the lithium-ion storage performance of perovskite SrxVO3-δ via Sr cation and O anion deficient engineering.

Perovskite SrVO3 has been investigated as a promising lithium storage anode where the V cation plays the role of the redox center, combining excellent cycle stability and safe operating potential versus Li metal plating, with limited capacity. Here, we demonstrate the possibility to boost the lithium storage properties, by reducing the non-redox active Sr cation content and fine-tuning the O anion vacancies while maintaining a non-stoichiometric SrxVO3-δ perovskite structure. Theoretical investigations suggest that Sr vacancy can work as favorable Li+ storage sites and preferential transport channels for guest Li+ ions, contributing to the increased specific capacity and rate performance. In contrast, inducing O anion vacancy in SrxVO3-δ can improve rate performance while compromising the specific capacity. Our experimental results confirm the enhancement of specific capacities by fine adjusting the Sr and O vacancies, with a maximum capacity of 444 mAh g-1 achieved with Sr0.63VO3-δ, which is a 37% increase versus stoichiometric SrVO3. Although rich defects have been induced, SrxVO3-δ electrodes maintain a stable perovskite structure during cycling versus a LiFePO4 cathode, and the full-cell could achieve more than 6000 discharge/charge cycles with 80% capacity retention. This result highlights the possibility to use the cation defective-based engineering approach to design high-capacity perovskite oxide anode materials.

Correction: Gao et al. TGF-ß1 Facilitates TAp63α Protein Lysosomal Degradation to Promote Pancreatic Cancer Cell Migration. Biology 2021, 10, 597.

In the original publication [...].

Cu/PCN Metal-Semiconductor Heterojunction by Thermal Reduction for Photoreaction of CO2-Aerated H2O to CH3OH and C2H5OH.

g-C3N4-based materials show potential for photoreduction of CO2 to oxygenates but are subjected to fast recombination of photogenerated charge carriers. Here, a novel Cu-dispersive protonated g-C3N4 (PCN) metal-semiconductor (m-s) heterojunction from thermal reduction of a Cu2O/PCN precursor was prepared and characterized using in situ X-ray diffraction, scanning transmission electron microscopy, X-ray photoelectron spectroscopy, ultraviolet-visible (UV-vis) spectra, photoluminescence (PL) spectra, transient photocurrent response, and electrochemical impedance spectroscopy (EIS). The Cu amount in Cu/PCN and the reduction temperature affected the generation of CH3OH and C2H5OH from the photoreaction of CO2-aerated H2O. During calcination of Cu2O/PCN in N2 at 550 °C, Cu2O was completely reduced to Cu with even dispersion, and a m-s heterojunction was obtained. With thermal exfoliation, Cu/PCN showed a specific surface area and layer spacing larger than those of PCN. Cu/PCN-0.5 (12.8 wt % Cu) exhibited a total carbon yield of 25.0 µmol·g-1 under UV-vis irradiation for 4 h, higher than that of Cu2O/PCN (13.6 µmol·g-1) and PCN (6.0 µmol·g-1). The selectivity for CH3OH and C2H5OH was 51.42 and 46.14%, respectively. The PL spectra, transient photocurrent response, and EIS characterizations indicated that Cu/PCN heterojunction promotes the separation of electrons and holes and suppresses their recombination. The calculated conduction band position was more negative, which is conducive to the multielectron reactions for CH3OH and C2H5OH generation.

Perovskite-Type SrVO3 as High-Performance Anode Materials for Lithium-Ion Batteries.

Perovskite-type oxides, characterized by excellent multifunctional physical and chemical properties, are widely used in ferroelectric, piezoelectric, energy conversion, and storage applications. It is shown here that the perovskite-type SrVO3 can achieve excellent electrochemical performance as lithium-ion battery anodes thanks to its high electrically and ionically conductivity. Conducting additive-free SrVO3 electrodes can deliver a high specific capacity of 324 mAh g-1 at a safe and low average working potential of ≈0.9 V vs Li/Li+ together with excellent high-rate performance. A high areal capacity of ≈5.4 mAh cm-2 is obtained using an ultrathick (≈120 µm) electrode. Moreover, the fully lithiated SrVO3 electrode exhibits only 2.3% volume expansion that is explained by a simple solid-solution Li+ -storage mechanism, resulting in good cycling stability of the electrode. This study highlights the perovskite-type SrVO3 as a promising Li+ -storage anode and provides opportunities for exploring a variety of perovskite oxides as next-generation metal-ion battery anodes.

TGF-ß1 Facilitates TAp63α Protein Lysosomal Degradation to Promote Pancreatic Cancer Cell Migration.

TGF-ß signaling plays a pivotal role in promoting tumor cell migration and cancer metastasis. ΔNp63α and TAp63α are two major isoforms of p53-related p63 protein. Our recent study has shown that TGF-ß1 promotes ΔNp63α protein degradation to facilitate cancer metastasis. However, whether TAp63α is involved in TGF-ß1-induced cancer metastasis remains unclear. In this study, we show that, in human pancreatic cancer MIA PaCa-2 cells harboring p53-R248W allele, TGF-ß1 can significantly inhibit TAp63α protein stability in a Smad pathway-independent manner. Lysosome inhibitor, chloroquine, but not proteasome inhibitor MG132, can rescue TGF-ß1-induced downregulation of TAp63α protein. In addition, we show that either TGF-ß1 treatment or silencing of TAp63α can dramatically increase migration of MIA PaCa-2 cells. Importantly, the restored expression of TAp63α can effectively block TGF-ß1-induced migration of MIA PaCa-2 cells. Mechanistically, we show that TGF-ß1 promotes TAp63α protein degradation, leading to upregulation of p53-R248W protein expression, and consequently resulting in elevated MIA PaCa-2 cell migration. Together, this study indicates that lysosomal degradation is an important way for regulating TAp63α protein fate and highlights that TGF-ß1-TAp63α-mutant p53 axis is critically important in pancreatic cancer metastasis.

Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide.

Signal transducer and activator of transcription 3 (STAT3) has been confirmed as an attractive therapeutic target for cancer therapy. Herein, we designed and synthesized a series of N-substituted Sulfamoylbenzamide STAT3 inhibitors based on small-molecule STAT3 inhibitor Niclosamide. Compound B12, the best active compound of this series, was identified as an inhibitor of IL-6/STAT3 signaling with an IC50 of 0.61-1.11 µM in MDA-MB-231, HCT-116 and SW480 tumor cell lines with STAT3 overexpression, by inhibiting the phosphorylation of STAT3 of Tyr705 residue and the expression of STAT3 downstream genes, inducing apoptosis and inhibiting the migration of cancer cells. Furthermore, in vivo study revealed that compound B12 suppressed the MDA-MB-231 xenograft tumor growth in nude mice at the dose of 30 mg/kg (i.g.), which has better antitumor activity than the positive control Niclosamide. More importantly, B12 is an orally bioavailable anticancer agent as a promising candidate for further development.

Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases.

BACKGROUND: The coronavirus disease 2019 (COVID-19) outbreak has brought great challenges to public health. Aggravation of COVID-19 is closely related to the secondary systemic inflammatory response. Glucocorticoids are used to control severe diseases caused by the cytokine storm, owing to their anti-inflammatory effects. However, glucocorticoids are a double-edged sword, as the use of large doses has the potential risk of secondary infection and long-term serious complications, and may prolong virus clearance time. Nonetheless, the risks and benefits of glucocorticoid adjuvant therapy for COVID-19 are inconclusive. AIM: To determine the effect of methylprednisolone in severe and critically ill patients with COVID-19. METHODS: This single-center retrospective study included 102 adult COVID-19 patients admitted to a ward of a designated hospital in Wuhan, Hubei Province from January to March 2020. All patients received general symptomatic treatment and organ function support, and were given different respiratory support measures according to their conditions. In case of deterioration, considering the hyperinflammatory state of the patients, methylprednisolone was intravenously administered at 0.75-1.5 mg/kg/d, usually for less than 14 d. Patient vital signs and oxygenation were closely monitored, in combination with imaging and routine blood tests such as C-reactive protein, biochemical indicators (liver and kidney function, myocardial enzymes, electrolytes, etc.), and coagulation function. Patient clinical outcomes were discharge or death. RESULTS: A total of 102 severe and critically ill COVID-19 patients were included in this study. They were divided into treatment (69, 67.6%) and control groups (33, 32.4%) according to methylprednisolone use. Comparison of baseline data between the two groups showed that the treatment group patients had higher aspartic acid aminotransferase, globulin, hydroxybutyrate dehydrogenase, and lactate dehydrogenase. There was no significant difference in other baseline data between the two groups. With regard to prognosis, 29 (78.4%) patients in the treatment group died as opposed to 40 (61.5%) in the control group. The mortality was higher in the treatment group than in the control group; however, according to the log-rank test and the Kaplan-Meier survival curve, the difference in mortality between both groups was insignificant (P = 0.655). The COX regression equation was used to correct the variables with differences, and the results showed that methylprednisolone treatment did not improve prognosis. CONCLUSION: Methylprednisolone treatment does not improve prognosis in severe and critical COVID-19 patients.

Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19.

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. COVID-19 is clinically categorized into mild, moderate, severe, and critical illness. Acute kidney injury is an independent risk factor for poor prognosis in patients with. Serum cystatin C (sCys C) is considered a more sensitive biomarker for early renal insufficiency than conventional indicators of renal function. Early detection of risk factors that affect the prognosis of severe and critically ill patients while using active and effective treatment measures is very important and can effectively reduce the potential mortality rate. AIM: To determine the predictive value of sCys C for the prognosis of patients with COVID-19. METHODS: The clinical data of 101 severe and critically ill patients with COVID-19 at a designated hospital in Wuhan, Hubei Province, China were analyzed retrospectively. According to the clinical outcome, the patients were divided into a discharge group (64 cases) and a death group (37 cases). The general information, underlying diseases, and laboratory examination indexes of the two groups were compared. Multivariate Cox regression was used to explore the relationship between sCys C and prognosis. The receiver operating characteristic (ROC) curve was used to demonstrate the sensitivity and specificity of sCys C and its optimal cut-off value for predicting death. RESULTS: There were significant differences in age, sCys C, creatinine, C-reactive protein, serum albumin, creatine kinase-MB, alkaline phosphatase, lactate dehydrogenase, neutrophil count, and lymphocyte count between the two groups (P < 0.001). Multivariate logistic regression analysis showed that sCys C was an independent risk factor for death in patients with COVID-19 (Odds ratio = 1.812, 95% confidence interval [CI]: 1.300-2.527, P < 0.001). The area under the ROC curve was 0.755 (95%CI: 1.300-2.527), the cut-off value was 0.80, the specificity was 0.562, and the sensitivity was 0.865. CONCLUSION: sCys C is an independent risk factor for death in patients with COVID-19. Patients with a sCys C level of 0.80 mg/L or greater are at a high risk of death.

Pd-Ru nanocatalysts derived from a Pd-induced aerogel for dramatic boosting of hydrogen release.

Alloyed bimetallic Pd-Ru nanocatalysts prepared by in situ reduction of a mixture of a Ru(iii) source and a Pd(ii)@alkyne-PVA aerogel and characterized by TEM and XPS exhibit very highly catalytic activity towards hydrogen release from ammonia borane hydrolysis with a TOF value of 578.2 molH2 molcat-1 min-1.

Electrochemical oxidation of methyl orange by a Magnéli phase Ti4O7 anode.

In this study, high quality Magnéli phase Ti4O7 bulks with electrical conductivity up to 961.5 S cm-1 were successfully prepared by spark plasma sintering (SPS) and then served as electrode materials for electrochemical oxidation of azo dye methyl orange (MO). The influences of current density and initial dye concentration on the removal rates of MO and chemical oxygen demand (COD) were studied. Removal of MO and COD exhibited an increase with increasing current density and decreasing initial concentration of MO. Complete removal of MO was realized within a short time under all experimental conditions. The removal rate of COD reached 91.7% when current density was 10 mA cm-2 and initial dye concentration was 100 mg L-1. In addition, the electrochemical oxidation rate could be described through a pseudo-first-order kinetic constant k, and the obtained experimental results could be well fitted with a proposed kinetic model in all the examined conditions. Possible degradation mechanisms for electrochemical oxidation of MO by Ti4O7 electrode were proposed on the basis of intermediate products analysis. Tests were also conducted with other commercial electrodes for comparison, including commercial graphite, stainless-steel and dimension stable anode (DSA) electrodes. The results showed that Ti4O7 anode exhibited the fastest electrochemical oxidation rates than those of the other electrodes. This study provides a feasible method for realizing high efficiency of electrochemical oxidation degradation by Ti4O7 electrode.

Nanoscale zero-valent iron intercalated 2D titanium carbides for removal of Cr(VI) in aqueous solution and the mechanistic aspect.

MXenes, as new members of the 2D materials group, are regarded as good candidates for heavy metal removal particularly for radioactive metal element because of their high irradiation stability. However, the small interlayer distance and lack of active sites on the surface limit their further application. In this report, nanoscale zero-valent iron has been introduced into the inter-layer structure of alkaline intercalated Ti3C2 (Alk-Ti3C2) and investigated to Cr(VI) removal. The XPS spectra, SEM images, TEM images, and N2 adsorption-desorption isotherms characterizations revealed that the OH groups on the Alk-Ti3C2 surface assisted the introducing of nZVI into the inter-layer of Alk-Ti3C2 and subsequently stabilized the nZVI. The increased active sites of nZVI and extended interlayer space of Alk-Ti3C2 could improve the uptake capacity of Cr(VI) (194.87 mg/g at pH = 2). The highly efficient removal of Cr(VI) was maintained even in the presence of coexisting cations, which showed great potential for real environment remediation. Mechanistic study indicated that the synergistic effects of nZVI and Alk-Ti3C2 nanosheet in nZVI-Alk-Ti3C2 composites are keys for Cr(VI) removal.

Infrared induced repeatable self-healing and removability of mechanically enhanced graphene-epoxy flexible materials.

A repeatable self-healing epoxy composite mechanically enhanced by graphene nanosheets (GNS) was prepared from an epoxy monomer with Diels-Alder (DA) bonds, octanediol glycidyl ether (OGE) and polyether amine (D230). The GNS/epoxy composites, with a maximum tensile modulus of 14.52 ± 0.45 MPa and elongation at break more than 100%, could be healed several times under Infrared (IR) light with the healing efficiency as high as 90% through the molecule chain mobility and the rebonding of reversible DA bonds between furan and maleimide. Also, they displayed excellent recyclable ability by transforming into a soluble polymer, which offers a wide range of possibilities to produce epoxy flexible materials with healing and removable abilities.

TiO2-Au composite nanofibers for photocatalytic hydrogen evolution.

TiO2-based materials for photocatalytic hydrogen (H2) evolution have attracted much interest as a renewable approach for clean energy applications. TiO2-Au composite nanofibers (NFs) with an average fiber diameter of ∼160 nm have been fabricated by electrospinning combined with calcination treatment. In situ reduced gold nanoparticles (NPs) with uniform size (∼10 nm) are found to disperse homogenously in the TiO2 NF matrix. The TiO2-Au composite NFs catalyst can significantly enhance the photocatalytic H2 generation with an extremely high rate of 12 440 µmol g-1 h-1, corresponding to an adequate apparent quantum yield of 5.11% at 400 nm, which is 25 times and 10 times those of P25 (584 µmol g-1 h-1) and pure TiO2 NFs (1254 µmol g-1 h-1), respectively. Furthermore, detailed studies indicate that the H2 evolution efficiency of the TiO2-Au composite NF catalyst is highly dependent on the gold content. This work provides a strategy to develop highly efficient catalysts for H2 evolution.

Hypoperfusion Induced by Preconditioning Treadmill Training in Hyper-Early Reperfusion After Cerebral Ischemia: A Laser Speckle Imaging Study.

Exercise preconditioning induces neuroprotective effects during cerebral ischemia and reperfusion, which involves the recovery of cerebral blood flow (CBF). Mechanisms underlying the neuroprotective effects of re-established CBF following ischemia and reperfusion are unclear. The present study investigated CBF in hyper-early stage of reperfusion by laser speckle contrast imaging, a full-field high-resolution optical imaging technique. Rats with or without treadmill training were subjected to middle cerebral artery occlusion followed by reperfusion. CBF in arteries, veins, and capillaries in hyper-early stage of reperfusion (1, 2, and 3 h after reperfusion) and in subacute stage (24 h after reperfusion) were measured. Neurological scoring and 2,3,5-triphenyltetrazolium chloride staining were further applied to determine the neuroprotective effects of exercise preconditioning. In hyper-early stage of reperfusion, CBF in the rats with exercise preconditioning was reduced significantly in arteries and veins, respectively, compared to rats with no exercise preconditioning. Capillary CBF remained stable in the hyper-early stage of reperfusion, though it increased significantly 24 h after reperfusion in the rats with exercise preconditioning. As a neuroprotective strategy, exercise preconditioning reduced the blood perfusion of arteries and veins in the hyper-early stage of reperfusion, which indicated intervention-induced neuroprotective hypoperfusion after reperfusion onset.

Immunolocation and enzyme activity analysis of Cryptosporidium parvum enolase.

BACKGROUND: Enolase is an essential multifunctional glycolytic enzyme that is involved in many biological processes of apicomplexan protozoa, such as adhesion and invasion. However, the characteristics of enolase in Cryptosporidium parvum, including the location on the oocyst and the enzyme activity, remain unclear. METHODS: The C. parvum enolase gene (cpeno) was amplified by RT-PCR and sequenced. The deduced amino acid sequence was analysed by bioinformatics software. The gene was expressed in Escherichia coli BL21 (DE3) and purified recombinant protein was used for enzyme activity analysis, binding experiments and antibody preparation. The localisation of enolase on oocysts was examined via immunofluorescence techniques. RESULTS: A 1,350 bp DNA sequence was amplified from cDNA taken from C. parvum oocysts. The deduced amino acids sequence of C. parvum enolase (CpEno) had 82.1% homology with Cryptosporidium muris enolase, and 54.7-68.0% homology with others selected species. Western blot analysis indicated that recombinant C. parvum enolase (rCpEno) could be recognised by C. parvum-infected cattle sera. Immunolocalization testing showed that CpEno was found to locate mainly on the surface of oocysts. The enzyme activity was 33.5 U/mg, and the Michaelis constant (K m ) was 0.571 mM/l. Kinetic measurements revealed that the most suitable pH value was 7.0-7.5, and there were only minor effects on the activity of rCpEno with a change in the reaction temperature. The enzyme activity decreased when the Ca2+, K+, Mg2+ and Na+ concentrations of the reaction solution increased. The binding assays demonstrated that rCpEno could bind to human plasminogen. CONCLUSION: This study is the first report of immunolocation, binding activity and enzyme characteristics of CpEno. The results of this study suggest that the surface-associated CpEno not only functions as a glycolytic enzyme but may also participate in attachment and invasion process of the parasite.